Paolo Grumati | Cell Biology | Best Researcher Award

Posted on by Neuroscientists

Prof. Paolo Grumati | Cell Biology | Best Researcher Award

Prof. Paolo Grumati,  TIGEM, Italy.

Dr. Paolo Grumati is a prominent researcher and academic with a focus on molecular biology, particularly the study of autophagy and its role in diseases such as muscular dystrophies and neurodegenerative disorders. His academic journey, beginning with a Master’s and Ph.D. from the University of Padova, laid the foundation for his pioneering work in the molecular mechanisms underlying disease pathogenesis. Dr. Grumati’s professional endeavors have included roles at esteemed institutions like Johann Wolfgang Goethe University and the Telethon Institute of Genetics and Medicine (TIGEM), where he leads groundbreaking research in selective autophagy. His work, which integrates advanced techniques like CRISPR/Cas9, has earned him widespread recognition and numerous accolades, including positions as Associate Professor at the University of Naples. His research has had a significant impact on the scientific community, particularly in the areas of cellular maintenance and therapeutic development.

Profile

Scopus

 

Early Academic Pursuits 🎓


Paolo Grumati’s academic journey began at the University of Padova in Italy, where he pursued a Master’s Degree in Medical Biotechnologies, graduating in 2005. His deep curiosity in the molecular underpinnings of human biology led him to continue his studies with a Ph.D. in Genetic and Molecular Biology, completed between 2006 and 2009. During his Ph.D., he focused on the genetic mechanisms that contribute to various diseases, a pursuit that sparked his lasting interest in molecular biology and disease pathogenesis. His early academic training laid a strong foundation for his future research in the biochemistry of diseases, especially those that affect muscle function and cellular processes.

Professional Endeavors 💼


Dr. Grumati’s professional career has been marked by an impressive trajectory across prestigious institutions. After completing his postdoctoral work on the pathogenesis of muscular dystrophies at the University of Padova, he moved to Germany, where he took a position at the Institute of Biochemistry II at Johann Wolfgang Goethe University. There, between 2013 and 2018, he specialized in the biochemistry and molecular biology of autophagy, a crucial cellular process related to health and disease. His expertise in autophagy became a defining element of his career, and in 2019, he was appointed as the Assistant Investigator and Head of the Mass Spectrometry Core at the Telethon Institute of Genetics and Medicine (TIGEM), where he leads innovative research into the molecular mechanisms of selective autophagy. Throughout these roles, Dr. Grumati has built a reputation for integrating advanced techniques like CRISPR/Cas9 into his work, influencing the field of genetic research.

Contributions and Research Focus 🔬


Dr. Grumati’s research focus has consistently revolved around the intricate molecular processes that govern cellular maintenance and disease, particularly through the lens of autophagy. Since becoming a principal investigator in 2019, his work at TIGEM has concentrated on understanding the molecular mechanisms of selective autophagy, which plays a pivotal role in cellular health and disease. He has pioneered methods to study and manipulate these processes, contributing significantly to the understanding of diseases such as muscular dystrophies and neurodegenerative disorders. His research not only delves into the underlying biology of these conditions but also seeks to identify therapeutic targets that could help manage or even cure these diseases.

Accolades and Recognition 🏆


Dr. Grumati has received widespread recognition for his work in molecular biology and biochemistry. His contributions to the field of autophagy and muscle biology have been honored with leadership roles in prominent research teams, including his time as Team Leader of the Frankfurt CRISPR/Cas9 Screening Center. His excellence in research has earned him a faculty position as Assistant Professor at the University of Naples “Federico II” and an eventual promotion to Associate Professor in 2024. His expertise in mass spectrometry and molecular biology has also made him a sought-after figure in the scientific community, where he is frequently invited to collaborate on interdisciplinary research projects.

Impact and Influence 🌍


Dr. Grumati’s research has had a lasting impact on the scientific community, particularly in the fields of autophagy and muscular dystrophies. His work has influenced both theoretical and applied aspects of molecular biology, from basic research to potential therapeutic interventions. Through his leadership at TIGEM and his involvement in international collaborations, Dr. Grumati has helped to shape the direction of research into autophagy-related diseases. His studies have not only provided insights into the cellular mechanisms at play in these diseases but also paved the way for future therapeutic strategies. He is seen as a key figure in the advancement of precision medicine and molecular therapeutics.

Legacy and Future Contributions 🔮

As Dr. Grumati moves forward in his career, his contributions to the fields of genetics and molecular biology are expected to have a profound and lasting influence. His current work, focusing on selective autophagy, holds promise for the development of novel treatments for diseases that currently have limited therapeutic options. His legacy will likely include innovations in understanding cellular degradation processes and their application to genetic disorders and other diseases. The future of Dr. Grumati’s research will continue to explore the molecular intricacies of human health, offering the potential for breakthroughs in regenerative medicine and disease treatment.

Teaching and Mentorship 👨‍🏫


Beyond his research, Dr. Grumati has made a significant impact through his academic roles at the University of Naples. As an Associate Professor, he plays a key role in shaping the next generation of molecular biologists. His teaching focuses on imparting knowledge in genetics, biochemistry, and molecular biology, with an emphasis on practical research applications. His mentorship has helped guide many students and early-career researchers, who have gone on to make their own contributions to the field. Dr. Grumati’s ability to translate complex scientific concepts into accessible lessons ensures that his influence extends far beyond his own research.

Publication

  • Title: Cortico-striatal circuit mechanisms drive the effects of D1 dopamine agonists on memory capacity in mice through cAMP/PKA signalling
    Authors: M. de Risi, D. Cavezza, G. Torromino, P. Grumati, E. de Leonibus
    Year: 2025

 

  • Title: Two FAM134B isoforms differentially regulate ER dynamics during myogenesis
    Authors: V. Buonomo, K.O. Lohachova, A. Reggio, R.M. Bhaskara, P. Grumati
    Year: 2025

 

  • Title: Ezrin defines TSC complex activation at endosomal compartments through EGFR-AKT signaling
    Authors: G. Giamundo, D. Intartaglia, E. del Prete, R. De Cegli, I. Conte
    Year: 2025

 

  • Title: 3D Rotary Wet-Spinning (RoWS) Biofabrication Directly Affects Proteomic Signature and Myogenic Maturation in Muscle Pericyte–Derived Human Myo-Substitute
    Authors: A. Reggio, C. Fuoco, F. de Paolis, M. Costantini, C. Gargioli
    Year: 2025

 

  • Title: Cross-Linking Mass Spectrometry to Capture Protein Network Dynamics of Cell Membranome
    Authors: L. Santorelli, M. Costanzo, S. Petrosino, M. Ruoppolo, P. Grumati
    Year: 2025

 

  • Title: Mitochondrial mechanotransduction through MIEF1 coordinates the nuclear response to forces
    Authors: P. Romani, G. Benedetti, M. Cusan, G. Martello, S. Dupont
    Year: 2024

 

Conclusion


Dr. Paolo Grumati’s career exemplifies the integration of scientific inquiry with practical application, as his research continues to shed light on crucial molecular processes that affect human health. His contributions to the understanding of autophagy have opened new avenues for potential therapeutic strategies in treating genetic disorders and other diseases. As he continues to lead research at TIGEM and teach at the University of Naples, Dr. Grumati’s legacy is set to influence the fields of molecular biology, genetics, and medicine for years to come. His work remains pivotal in advancing both the theoretical understanding of disease mechanisms and the development of new therapeutic approaches, positioning him as a key figure in modern biomedical research.

Soumya Basu | miRNA Biology | Excellence Award (Any Scientific field)

Posted on by Neuroscientists

Dr. Soumya Basu | miRNA Biology | Excellence Award (Any Scientific field)

Dr. Soumya Basu, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute,  India.

Dr. Soumya Basu is a distinguished scientist and academic specializing in cancer and translational research. With a Ph.D. in Life Sciences and over 18 years of research experience, he has made significant contributions to understanding drug-resistant cancer and targeted therapies. His academic journey spans multiple disciplines, including microbiology, medical writing, and artificial intelligence applications in cancer research. As an Associate Professor at Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, he has played a pivotal role in scientific mentorship, research advancements, and cross-disciplinary collaborations. His expertise in molecular oncology, cell-based assays, and small molecule design has led to impactful research, widely recognized in the scientific community through publications and citations.

 

Profile

Google Scholar

 

Early Academic Pursuits 🎓

From an early stage, Dr. Soumya Basu exhibited a keen interest in the sciences, embarking on an academic journey that laid the foundation for an illustrious career in life sciences and cancer research. He earned a Bachelor of Science in Physics, Chemistry, and Mathematics from the University of Burdwan, followed by a Master’s degree in Microbiology from the University of Kalyani. His unwavering passion for research led him to pursue a Ph.D. in Life Sciences at Jadavpur University, focusing on reactive oxygen species-mediated targeted therapy in drug-resistant cancer. Further enhancing his expertise, he pursued an Advanced Diploma in Medical Writing and Regulatory Affairs and later completed an Advanced Postgraduate course in Artificial Intelligence and Machine Learning from the University of Texas at Austin, reinforcing his multidisciplinary approach to modern scientific research.

Professional Endeavors 🎮

Dr. Basu’s professional journey is marked by his dedication to academia and translational research. He currently serves as an Associate Professor and Principal Investigator at the Cancer and Translational Research Centre, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Pune. His tenure at Dr. D. Y. Patil Vidyapeeth spans over a decade, where he initially joined as an Assistant Professor before rising to his current role. Prior to this, he contributed significantly as a Research Associate at the Molecular Functional Imaging Laboratory, ACTREC, Tata Memorial Center, and held esteemed positions as a Senior Research Fellow at the Chittaranjan National Cancer Institute (CNCI) and a Project Assistant at Jadavpur University and the University of Calcutta. His early teaching career at Kulti College further highlights his commitment to education and mentorship.

Contributions and Research Focus 🧑‍�‍🔬

Dr. Basu’s research is deeply rooted in cancer therapeutics, particularly in drug-resistant malignancies. His work spans multiple domains, including animal cell culture, cell-based assays, small molecule design and validation, and non-coding RNA research. With a strong emphasis on translational research, he has been at the forefront of developing novel therapeutic strategies targeting drug-resistant cancer cells. His contributions to molecular oncology and biotechnology have paved the way for advancements in personalized medicine, integrating computational approaches like artificial intelligence and machine learning to enhance predictive models in cancer treatment.

Accolades and Recognition 🏆

Over his distinguished career, Dr. Basu has garnered widespread recognition for his contributions to scientific research. His prolific publication record, including books, book chapters, research articles, and technical reports, attests to his commitment to advancing knowledge in cancer biology. His Google Scholar profile boasts an H-index of 14, with over 550 citations, underscoring the impact of his research in the global scientific community. His expertise in scientific writing and editing has also made him a sought-after mentor and collaborator in academia.

Impact and Influence 📈

Dr. Basu’s work has had a profound impact on the field of oncology, with his research findings influencing therapeutic strategies and treatment paradigms. His mentorship and guidance have inspired numerous young researchers, fostering the next generation of scientists dedicated to battling cancer. His contributions extend beyond the laboratory, as he actively participates in knowledge dissemination through conferences, workshops, and academic collaborations. His ability to bridge the gap between fundamental research and clinical application has positioned him as a thought leader in the field.

Legacy and Future Contributions 🌟

As a scientist and educator, Dr. Basu’s legacy is defined by his relentless pursuit of innovation in cancer research. His ongoing work aims to refine targeted therapies, explore novel drug delivery systems, and harness artificial intelligence for more effective cancer diagnostics and treatment. With a vision to create a lasting impact on cancer care, he continues to drive transformative research initiatives. His unwavering commitment to scientific excellence ensures that his contributions will shape the future of oncology for years to come.

 

Publication

  1. Synthesis, spectroscopic characterization, X-ray powder structure analysis, DFT study and in vitro anticancer activity of N-(2-methoxyphenyl)-3-methoxysalicylaldimine

    • Authors: B Chattopadhyay, S Basu, P Chakraborty, SK Choudhuri, AK Mukherjee, …
    • Year: 2009

 

  1. Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate

    • Authors: A Ganguly, S Basu, P Chakraborty, S Chatterjee, A Sarkar, M Chatterjee, …
    • Year: 2010

 

  1. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach

    • Authors: KB Lokhande, S Ballav, RS Yadav, KV Swamy, S Basu
    • Year: 2022

 

  1. Use of BRET to study protein–protein interactions in vitro and in vivo

    • Authors: S Dimri, S Basu, A De
    • Year: 2016

 

  1. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis

    • Authors: A Ganguly, S Basu, K Banerjee, P Chakraborty, A Sarkar, M Chatterjee, …
    • Year: 2011

 

  1. PPAR-γ partial agonists in disease-fate decision with special reference to cancer

    • Authors: S Ballav, B Biswas, VK Sahu, A Ranjan, S Basu
    • Year: 2022

 

  1. Drug repurposing—an emerging strategy in cancer therapeutics

    • Authors: JA Khadija Shahab Turabi, Ankita Deshmukh, Sayan Paul, Dayanand Swami, S Basu
    • Year: 2022

 

  1. Exploring conformational changes of PPAR-Ɣ complexed with novel kaempferol, quercetin, and resveratrol derivatives to understand binding mode assessment: a small-molecule study

    • Authors: KB Lokhande, S Ballav, N Thosar, KV Swamy, S Basu
    • Year: 2020

 

Conclusion 🌟

Dr. Soumya Basu’s career is a testament to his unwavering dedication to cancer research and academia. His contributions to targeted therapies, translational oncology, and biomedical advancements continue to influence both scientific understanding and clinical applications. Through his mentorship and research initiatives, he is shaping the next generation of scientists while driving forward innovative solutions for cancer treatment. With his ongoing efforts in integrating AI with biomedical sciences, Dr. Basu remains at the forefront of cutting-edge cancer research, ensuring a lasting impact on the field.

 

 

 

 

Vikash Kumar | Molecular Biology | Best Researcher Award

Posted on by Neuroscientists

Dr. Vikash Kumar | Molecular Biology | Best Researcher Award

Dr. Vikash Kumar, Central Inland Fisheries Research Institute,  India.

Dr. Vikash Kumar is a distinguished scientist in the field of aquaculture and fish health management, with over 15 years of research experience. His academic journey, from earning a Ph.D. with distinction at Ghent University to holding key research positions at ICAR-CIFRI, has been marked by excellence. His expertise spans transcriptomics, proteomics, cellular biology, and immunohistochemistry, with a strong focus on understanding fish and shrimp immunological responses. His groundbreaking research on Acute Hepatopancreatic Necrosis Disease (AHPND) in shrimp and inflammation in Labeo rohita has significantly contributed to disease mitigation strategies in aquaculture. Recognized among the Top 2% of Scientists globally (Stanford/Elsevier, 2024), Dr. Kumar’s influence extends beyond research, shaping policies and fostering international collaboration.

profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Vikash Kumar’s journey into the world of aquaculture and fish health began with a strong academic foundation. With a Bachelor of Fisheries Science from the College of Fisheries, India, he excelled in his studies, earning first-class distinction with an impressive 8.66/10.0 GPA. Building upon this, he pursued a Master of Fisheries Science in Fish Health from ICAR-Central Institute of Fisheries Education (CIFE), India, where he once again showcased academic brilliance, securing an 8.23/10.0 GPA. His thirst for knowledge and dedication to research led him to Belgium, where he earned his Ph.D. from the esteemed Laboratory of Aquaculture & Artemia Reference Center, Ghent University, in 2020. Awarded with distinction, his doctoral studies solidified his expertise in fish and shrimp immunology, setting the stage for a remarkable scientific career.

🏅 Professional Endeavors

With more than 15 years of experience in aquaculture and fish health management, Dr. Kumar has made significant strides in his field. His professional journey began in 2014 as a Scientist at the ICAR-Central Inland Fisheries Research Institute (ICAR-CIFRI) in Kolkata, India. After four years of dedicated service, he embarked on his doctoral research at Ghent University, where he explored critical aspects of aquatic immunology. Returning to ICAR-CIFRI in 2020 as a Senior Scientist, he continues to contribute to the advancement of fisheries research, working with diverse stakeholders and scientists to address pressing challenges in the aquaculture industry.

🔬 Contributions and Research Focus

Dr. Kumar’s research spans a broad spectrum of critical topics in aquaculture. His expertise in transcriptomics, proteomics, cellular biology, histology, immunohistochemistry, and electron microscopy has enabled him to unravel complex immunological responses in fish and shrimp. His work has provided invaluable insights into the virulence and pathogenesis of Acute Hepatopancreatic Necrosis Disease (AHPND) in shrimp, leading to the development of innovative mitigation strategies. Additionally, his research on carrageenan-induced inflammation in Labeo rohita has contributed to a deeper understanding of fish immune responses, paving the way for improved disease management in aquaculture.

🏆 Accolades and Recognition

Dr. Kumar’s contributions to fisheries science have earned him global recognition. He is ranked among the Top 2% of Scientists worldwide as per Stanford/Elsevier rankings in 2024, a testament to his impactful research and scientific excellence. His work is widely acknowledged in the scientific community, reflecting his dedication to enhancing the health and sustainability of aquatic species. His commitment to continuous learning and innovation has made him a respected figure in fisheries research, both in India and internationally.

🌍 Impact and Influence

Dr. Kumar’s research has significantly influenced disease management strategies in aquaculture, directly benefiting the fisheries industry. His work has helped improve diagnostic methods, develop novel treatment approaches, and enhance the overall resilience of aquaculture systems against infectious diseases. His ability to collaborate with researchers worldwide has fostered the exchange of knowledge, strengthening the global scientific network dedicated to sustainable aquaculture practices.

🔬 Legacy and Future Contributions

As a dedicated scientist, Dr. Kumar’s legacy is defined by his relentless pursuit of solutions for aquaculture challenges. His research continues to inspire young scientists, and his contributions are shaping the future of fish health management. Moving forward, he aims to expand his studies on disease mitigation strategies, explore cutting-edge biotechnological approaches, and contribute to policy frameworks that promote sustainable fisheries. His unwavering commitment to scientific advancement ensures that his impact will resonate for generations to come.Dr. Vikash Kumar stands as a beacon of excellence in aquaculture research, transforming the field with his expertise, passion, and vision for a healthier aquatic future.

publication

  • Genus Bacillus, Promising Probiotics in Aquaculture: Aquatic Animal Origin, Bio-Active Components, Bioremediation and Efficacy in Fish and Shellfish
    Authors: M Soltani, K Ghosh, SH Hoseinifar, V Kumar, AJ Lymbery, S Roy, E Ringø
    Year: 2019

 

  • Application of Probiotics in Shrimp Aquaculture: Importance, Mechanisms of Action, and Methods of Administration
    Authors: V Kumar, S Roy, DK Meena, UK Sarkar
    Year: 2016

 

  • Acute Hepatopancreatic Necrosis Disease (AHPND): Virulence, Pathogenesis and Mitigation Strategies in Shrimp Aquaculture
    Authors: V Kumar, S Roy, BK Behera, P Bossier, BK Das
    Year: 2021

 

  • Immunostimulants for Aquaculture Health Management
    Authors: D Barman, P Nen, SC Mandal, V Kumar
    Year: 2013

 

  • A Practical Approach on SDS PAGE for Separation of Protein
    Authors: S Roy, V Kumar
    Year: 2014

 

  • Phloroglucinol-Mediated Hsp70 Production in Crustaceans: Protection Against Vibrio Parahaemolyticus in Artemia Franciscana and Macrobrachium Rosenbergii
    Authors: V Kumar, K Baruah, DV Nguyen, G Smagghe, E Vossen, P Bossier
    Year: 2018

 

  • Biofloc Microbiome with Bioremediation and Health Benefits
    Authors: V Kumar, S Roy, BK Behera, BK Das
    Year: 2021

 

  • Acute Phase Proteins and Their Potential Role as an Indicator for Fish Health and in Diagnosis of Fish Diseases
    Authors: S Roy, V Kumar, V Kumar, BK Behera
    Year: 2017

 

Conclusion

Dr. Vikash Kumar’s contributions to aquaculture science are both profound and far-reaching. His work not only advances scientific understanding but also provides practical solutions for the sustainable growth of the fisheries industry. His dedication to innovation, research, and global collaboration cements his status as a leading scientist in his field. As he continues his pursuit of excellence, his impact on aquatic health management will undoubtedly shape the future of sustainable aquaculture and inspire upcoming generations of researchers. 🌊🐠

Dinh Phong Son | CircRNA | Best Researcher Award

Posted on by Neuroscientists

Dr. Dinh Phong Son | CircRNA | Best Researcher Award

Dr. DINH PHONG SON, DUYTAN UNIVERSITY, Vietnam.

Dr. Dinh Phong Son is a researcher specializing in laboratory medicine techniques with a Ph.D. in Molecular Medicine from Guangxi Medical University, China. His research focuses on modern molecular biology techniques, particularly the identification of potential biomarkers for early disease diagnosis and targeted therapy. His studies explore systemic diseases such as diabetes, cardiovascular diseases, and cancer, emphasizing gene editing technologies like CRISPR/Cas9. His recent publications contribute to the understanding of regulatory RNA networks and their implications in disease mechanisms, providing a foundation for future studies on molecular interactions and targeted drug development.

Profile

Orcid

 

🎓 Early Academic Pursuits

From the very beginning of my academic journey, I was deeply fascinated by the intricate mechanisms of life at a molecular level. My pursuit of knowledge led me to study Laboratory Medicine Technique at Hue University of Medicine and Pharmacy, Vietnam, where I honed my expertise in diagnostic methodologies and medical laboratory sciences. With an insatiable thirst for discovery, I furthered my education by earning a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China. This academic foundation set the stage for my dedication to the field of molecular biology, shaping my vision to explore genetic markers and innovative diagnostic tools.

👩‍🎓 Professional Endeavors

Currently, I serve at Duy Tan University, College of Medicine and Pharmacy, where I actively contribute to research, mentoring, and academic discourse. My work primarily revolves around molecular diagnostics, genetic analysis, and disease biomarker identification, aiming to bridge the gap between molecular biology and clinical applications. With advancements in next-generation sequencing (NGS) and bioinformatics databases, I continually seek new pathways to enhance the precision of disease detection and treatment strategies.

🧪 Contributions and Research Focus

My research is deeply rooted in molecular medicine, focusing on the identification of potential biomarkers for the early diagnosis of systemic diseases such as diabetes, cardiovascular diseases, stroke, and cancer. My investigations also extend to exploring gene targets for pharmacological studies, assisting in drug development through the modulation of gene expression using cutting-edge technologies like CRISPR/Cas9, gene overexpression, and silencing approaches. Furthermore, my work delves into the complex LncRNA/CircRNA/miRNA/gene/protein-drug interaction networks, paving the way for theoretical models that could revolutionize targeted therapy research.

 

💎 Impact and Influence

The impact of my research extends beyond academia, as it plays a crucial role in early disease screening, personalized medicine, and therapeutic advancements. By leveraging molecular networks, I aim to facilitate the development of precise diagnostic tools and gene-targeted interventions, significantly improving patient outcomes. My research findings have the potential to reshape biomedical applications and create avenues for innovative treatment strategies across various diseases.

🌟 Legacy and Future Contributions

Looking ahead, my aspirations remain steadfast in expanding molecular biology research, particularly in uncovering novel biomarkers and refining gene-editing techniques. As the field continues to evolve, I hope to contribute to the refinement of therapeutic gene modifications and biomarker-based diagnostics. With sustained efforts and collaborations, I envision a future where my research serves as a cornerstone for breakthroughs in precision medicine, targeted gene therapy, and advanced molecular diagnostics.

👨‍💼 Professional Collaborations and Memberships

As an active member of the scientific community, I engage in collaborations and professional affiliations to foster knowledge exchange and multidisciplinary research. My involvement in editorial appointments, consultancy projects, and industry partnerships enables me to extend my research impact, ensuring that molecular medicine continues to advance for the benefit of humanity.

 

Publication

  • Title: Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on Microarray Data analysis, molecular docking, and dynamic simulation
    Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Hai-Anh Ha, Aigul Utegenova, Awais Ali, Abdulaziz Alamri
    Year: 2025

 

  • Title: Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1
    Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Awais Ali, ShangLing Pan
    Year: 2024

 

  • Title: Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data
    Authors: ChauMyThanh Tran, PhongSon Dinh
    Year: 2024

 

  • Title: Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease
    Authors: PhongSon Dinh, JunHua Peng, ThanhLoan Tran, DongFeng Wu, ChauMyThanh Tran, ThiPhuongHoai Dinh, ShangLing Pan
    Year: 2023

 

  • Title: Construction of miRNAs and gene expression profiles associated with ischemic cardiomyopathy: Bioinformatics analysis
    Authors: PhongSon Dinh, Jun-Hua Peng, ChauMyThanh Tran, ThanhLoan Tran, Shang-Ling Pan
    Year: 2022

 

Conclusion

Dr. Son’s research plays a crucial role in advancing molecular biology by identifying key biomarkers and regulatory networks for disease screening and treatment. His work in gene-targeted therapy and RNA interaction networks lays the groundwork for future innovations in precision medicine. Despite challenges in resources and time, his commitment to molecular research aims to drive further advancements in understanding and treating complex diseases.